{"id":"https://openalex.org/W1479904201","doi":null,"title":"Src kinase inhibitor PP2 increases intrinsic gemcitabine sensitivity and attenuates acquired resistance in pancreatic cancer cells.","display_name":"Src kinase inhibitor PP2 increases intrinsic gemcitabine sensitivity and attenuates acquired resistance in pancreatic cancer cells.","alternate_titles":[],"publication_year":2003,"publication_date":"2003-01-01","ids":{"openalex":"https://openalex.org/W1479904201","mag":"1479904201"},"language":"en","primary_location":{"id":"mag:1479904201","doi":null,"is_oa":false,"landing_page_url":"https://www.research.ed.ac.uk/portal/en/publications/src-kinase-inhibitor-pp2-increases-intrinsic-gemcitabine-sensitivity-and-attenuates-acquired-resistance-in-pancreatic-cancer-cells(cec68c9b-036e-4be4-8694-c26a5440e523)/export.html","pdf_url":null,"source":null,"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":null,"raw_type":null},"parent_works":[],"lineage":["https://openalex.org/W1479904201"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":[],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5109084855","display_name":"Mark S. Duxbury","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Mark Duxbury","raw_affiliation_strings":["Deanery of Clinical Sciences"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Deanery of Clinical Sciences","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5041999667","display_name":"Hidenori Ito","orcid":"https://orcid.org/0000-0002-6527-477X","observed_orcids":["https://orcid.org/0000-0002-6527-477X","https://orcid.org/0000-0003-4186-406X"]},"institutions":[],"countries":[],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Hidenori Ito","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5084502636","display_name":"Michael J. Zinner","orcid":"https://orcid.org/0009-0006-9833-6750","observed_orcids":["https://orcid.org/0009-0006-9833-6750"]},"institutions":[],"countries":[],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Michael J. Zinner","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0009-0006-9833-6750","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5110133768","display_name":"S. W. Ashley","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"S. W. Ashley","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"last","author":{"id":"https://openalex.org/A5072328168","display_name":"Edward E. Whang","orcid":"https://orcid.org/0000-0003-2300-0647","observed_orcids":["https://orcid.org/0000-0003-2300-0647"]},"institutions":[],"countries":[],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"EE Whang","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":0.0,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":{"value":0.0,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":null,"biblio":{"volume":null,"issue":null,"first_page":null,"last_page":null},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10231","display_name":"Pancreatic and Hepatic Oncology Research","score":0.9839000105857849,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10231","display_name":"Pancreatic and Hepatic Oncology Research","score":0.9839000105857849,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10760","display_name":"Pancreatitis Pathology and Treatment","score":0.00279999990016222,"subfield":{"id":"https://openalex.org/subfields/2746","display_name":"Surgery"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10570","display_name":"Drug Transport and Resistance Mechanisms","score":0.0017000000225380063,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/pp2","display_name":"PP2","score":0.8270000219345093},{"id":"https://openalex.org/keywords/src-inhibitors","display_name":"Src kinase inhibitor","score":0.9589999914169312},{"id":"https://openalex.org/keywords/gemcitabine","display_name":"gemcitabine","score":0.9860000014305115},{"id":"https://openalex.org/keywords/acquired-drug-resistance","display_name":"acquired drug resistance","score":0.9779999852180481},{"id":"https://openalex.org/keywords/pancreatic-cancer","display_name":"pancreatic cancer","score":0.8360000252723694},{"id":"https://openalex.org/keywords/chemoresistance","display_name":"chemoresistance","score":0.7609999775886536}],"concepts":[{"id":"https://openalex.org/C2780258809","wikidata":"https://www.wikidata.org/wiki/Q414143","display_name":"Gemcitabine","level":3,"score":0.8311179876327515},{"id":"https://openalex.org/C108636557","wikidata":"https://www.wikidata.org/wiki/Q21109354","display_name":"Proto-oncogene tyrosine-protein kinase Src","level":3,"score":0.6751039624214172},{"id":"https://openalex.org/C2780210213","wikidata":"https://www.wikidata.org/wiki/Q212961","display_name":"Pancreatic cancer","level":3,"score":0.582105278968811},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.528235137462616},{"id":"https://openalex.org/C2779536868","wikidata":"https://www.wikidata.org/wiki/Q419940","display_name":"Dasatinib","level":4,"score":0.5201242566108704},{"id":"https://openalex.org/C184235292","wikidata":"https://www.wikidata.org/wiki/Q421851","display_name":"Kinase","level":2,"score":0.51945561170578},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.4638943672180176},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.4204234480857849},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.4195185899734497},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.3215157687664032},{"id":"https://openalex.org/C170493617","wikidata":"https://www.wikidata.org/wiki/Q208467","display_name":"Receptor","level":2,"score":0.1727760136127472},{"id":"https://openalex.org/C42362537","wikidata":"https://www.wikidata.org/wiki/Q87099740","display_name":"Tyrosine kinase","level":3,"score":0.16087639331817627},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.1456044316291809}],"mesh":[],"locations_count":1,"locations":[{"id":"mag:1479904201","doi":null,"is_oa":false,"landing_page_url":"https://www.research.ed.ac.uk/portal/en/publications/src-kinase-inhibitor-pp2-increases-intrinsic-gemcitabine-sensitivity-and-attenuates-acquired-resistance-in-pancreatic-cancer-cells(cec68c9b-036e-4be4-8694-c26a5440e523)/export.html","pdf_url":null,"source":null,"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":null,"raw_type":null}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":0.9537000060081482,"display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2117844134","https://openalex.org/W2292831797","https://openalex.org/W1963721493","https://openalex.org/W3118938059","https://openalex.org/W1568317880","https://openalex.org/W2343453515","https://openalex.org/W2088033220","https://openalex.org/W3024332504","https://openalex.org/W3010612400","https://openalex.org/W4384342799"],"abstract_inverted_index":null,"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W1479904201","counts_by_year":[],"updated_date":"2026-11-14T11:04:58.165337","created_date":"2016-06-24T00:00:00"}
